Q3 2017 EPS Estimates for Omega Healthcare Investors Inc (NYSE:OHI) Decreased by Analyst
Omega Healthcare Investors Inc (NYSE:OHI) – Jefferies Group dropped their Q3 2017 earnings per share estimates for shares of Omega Healthcare Investors in a research report issued to clients and investors on Thursday. Jefferies Group analyst O. Okusanya now forecasts that the real estate investment trust will post earnings per share of $0.81 for the quarter, down from their previous estimate of $0.85. Jefferies Group currently has a “Hold” rating and a $33.00 target price on the stock. Jefferies Group also issued estimates for Omega Healthcare Investors’ Q1 2018 earnings at $0.81 EPS, Q2 2018 earnings at $0.81 EPS, Q3 2018 earnings at $0.81 EPS and Q4 2018 earnings at $0.81 EPS.
OHI has been the subject of a number of other reports. BidaskClub raised Omega Healthcare Investors from a “hold” rating to a “buy” rating in a report on Thursday, June 22nd. Vetr cut Omega Healthcare Investors from a “hold” rating to a “sell” rating and set a $32.50 price target for the company. in a report on Monday, April 17th. Finally, Zacks Investment Research cut Omega Healthcare Investors from a “hold” rating to a “sell” rating in a report on Thursday, June 8th. Two research analysts have rated the stock with a sell rating and five have given a hold rating to the company. The stock currently has an average rating of “Hold” and an average price target of $34.38.
COPYRIGHT VIOLATION WARNING: This story was first reported by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/08/07/q3-2017-eps-estimates-for-omega-healthcare-investors-inc-nyseohi-decreased-by-analyst.html.
Shares of Omega Healthcare Investors (NYSE:OHI) opened at 30.95 on Monday. The firm has a market capitalization of $6.10 billion, a P/E ratio of 16.33 and a beta of 0.50. The firm has a 50 day moving average price of $33.05 and a 200-day moving average price of $32.65. Omega Healthcare Investors has a 52 week low of $28.11 and a 52 week high of $38.09.
Omega Healthcare Investors (NYSE:OHI) last issued its earnings results on Wednesday, July 26th. The real estate investment trust reported $0.33 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.49 by $0.16. Omega Healthcare Investors had a return on equity of 6.81% and a net margin of 28.67%. The company had revenue of $194 million during the quarter, compared to analyst estimates of $194.59 million. During the same period last year, the business earned $0.87 earnings per share. The firm’s revenue was up 4.0% compared to the same quarter last year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, August 15th. Investors of record on Tuesday, August 1st will be paid a $0.64 dividend. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.63. This represents a $2.56 annualized dividend and a yield of 8.27%. The ex-dividend date is Friday, July 28th. Omega Healthcare Investors’s dividend payout ratio is presently 135.45%.
In related news, COO Daniel J. Booth sold 20,000 shares of the company’s stock in a transaction on Monday, June 26th. The stock was sold at an average price of $34.65, for a total value of $693,000.00. Following the completion of the transaction, the chief operating officer now directly owns 90,335 shares in the company, valued at $3,130,107.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Craig R. Callen bought 15,000 shares of the company’s stock in a transaction that occurred on Friday, June 2nd. The stock was acquired at an average price of $31.40 per share, with a total value of $471,000.00. Following the completion of the purchase, the director now directly owns 18,000 shares of the company’s stock, valued at approximately $565,200. The disclosure for this purchase can be found here. Corporate insiders own 4.54% of the company’s stock.
A number of institutional investors have recently added to or reduced their stakes in OHI. Tompkins Financial Corp acquired a new position in Omega Healthcare Investors during the first quarter valued at approximately $165,000. Chicago Partners Investment Group LLC raised its position in Omega Healthcare Investors by 656.6% in the second quarter. Chicago Partners Investment Group LLC now owns 6,015 shares of the real estate investment trust’s stock valued at $193,000 after buying an additional 5,220 shares during the last quarter. South Texas Money Management Ltd. acquired a new position in Omega Healthcare Investors during the first quarter valued at approximately $207,000. Lodestar Investment Counsel LLC IL acquired a new position in Omega Healthcare Investors during the first quarter valued at approximately $209,000. Finally, Wesbanco Bank Inc. acquired a new position in Omega Healthcare Investors during the first quarter valued at approximately $211,000. Hedge funds and other institutional investors own 73.95% of the company’s stock.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
Receive News & Ratings for Omega Healthcare Investors Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc and related companies with MarketBeat.com's FREE daily email newsletter.